Denosumab is a type of drug called a monoclonal antibody. These drugs are sometimes called targeted therapies. They work by ‘targeting’ specific proteins (receptors) on the surface of cells.
There are two different types of denosumab. Each has its own brand name. Which one you have will depend on your situation.
Xgeva® is given to people with cancer that has spread to the bones (secondary bone cancer) from a solid tumour. A solid tumour is a cancer that occurs in one of the body’s organs, such as the breast, kidney or lung, but not a blood cancer, like myeloma or leukaemia.
Prolia® can be given to men with prostate cancer who may have weakened bones from having hormonal therapy. It may also be given to some post-menopausal women with breast cancer who may have weakened bones.